GR3006775T3 - - Google Patents

Info

Publication number
GR3006775T3
GR3006775T3 GR920402400T GR920402400T GR3006775T3 GR 3006775 T3 GR3006775 T3 GR 3006775T3 GR 920402400 T GR920402400 T GR 920402400T GR 920402400 T GR920402400 T GR 920402400T GR 3006775 T3 GR3006775 T3 GR 3006775T3
Authority
GR
Greece
Application number
GR920402400T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8809218A external-priority patent/FR2633928B1/fr
Priority claimed from FR8902167A external-priority patent/FR2643265B1/fr
Application filed filed Critical
Publication of GR3006775T3 publication Critical patent/GR3006775T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GR920402400T 1988-07-07 1993-01-14 GR3006775T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8809218A FR2633928B1 (fr) 1988-07-07 1988-07-07 Derives de (aza)naphtalenesultame, leurs procedes de preparation et les medicaments les contenant
FR8902167A FR2643265B1 (fr) 1989-02-20 1989-02-20 Derives de (aza)naphto(1,8-cd)isothiazole dioxyde-1,1 leurs procedes de preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
GR3006775T3 true GR3006775T3 (https=) 1993-06-30

Family

ID=26226778

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402400T GR3006775T3 (https=) 1988-07-07 1993-01-14

Country Status (18)

Country Link
US (2) US5021420A (https=)
EP (1) EP0350403B1 (https=)
JP (1) JP2763791B2 (https=)
KR (1) KR0138908B1 (https=)
AU (1) AU620114B2 (https=)
CA (1) CA1326483C (https=)
DE (1) DE68904364T2 (https=)
DK (1) DK335489A (https=)
ES (1) ES2054057T3 (https=)
FI (1) FI93114C (https=)
GR (1) GR3006775T3 (https=)
HU (1) HU210833B (https=)
IE (1) IE62364B1 (https=)
IL (1) IL90858A (https=)
NO (1) NO179007C (https=)
NZ (1) NZ229856A (https=)
PT (1) PT91098B (https=)
TW (1) TW197440B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663635A2 (fr) * 1989-12-26 1991-12-27 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2656306A1 (fr) * 1989-12-26 1991-06-28 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
US5202321A (en) * 1991-06-13 1993-04-13 Merck Frosst Canada, Inc. Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
FR2687575A1 (fr) * 1992-02-24 1993-08-27 Rhone Poulenc Rorer Sa Application du [[(fluoro-4 phenyl)-4 piperazinyl-1]-3 propyl]-2 2h naphto [1,8-cd] isothiazole dioxyde-1,1 pour obtenir un medicament anorexigene.
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
CN1058492C (zh) * 1993-12-24 2000-11-15 三得利株式会社 苯并噻嗪衍生物
US6001827A (en) 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
GB9416571D0 (en) * 1994-08-16 1994-10-12 Battelle Memorial Institute Novel alkylamino derivatives as sigma 2 selective ligands
SE9902765D0 (sv) 1999-07-21 1999-07-21 Astra Pharma Prod Novel compounds
US6521630B1 (en) 1999-08-31 2003-02-18 Pfizer Inc. Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
US6844338B2 (en) 2000-05-18 2005-01-18 Eli Lilly And Company Piperidyindoles as serotonin receptor ligands
DE602006021704D1 (de) * 2005-02-25 2011-06-16 Kowa Co Verfahren zur herstellung eines 4-fluorisochinolin-5-sulfonylhalogenids oder eines salzes davon
AU2008220104B2 (en) 2007-02-28 2012-09-27 Asahi Kasei Pharma Corporation Sulfonamide derivative
ES2595240T3 (es) 2012-07-09 2016-12-28 Lupin Limited Derivados de tetrahidroquinazolinona como inhibidores de PARP
CN108299411B (zh) * 2017-01-13 2021-02-05 中国人民解放军军事医学科学院毒物药物研究所 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755589A (fr) * 1969-09-03 1971-03-02 Janssen Pharmaceutica Nv Benzimidazoolcarbamaten
DE2139084C3 (de) * 1971-08-04 1979-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
JPS59229556A (ja) * 1983-06-13 1984-12-24 Konishiroku Photo Ind Co Ltd 熱現像カラ−感光要素
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8510840D0 (en) * 1985-04-29 1985-06-05 Allied Corp Electrical connectors

Also Published As

Publication number Publication date
NZ229856A (en) 1990-08-28
AU3790689A (en) 1990-01-11
NO892808L (no) 1990-01-08
NO179007B (no) 1996-04-09
FI93114B (fi) 1994-11-15
IL90858A0 (en) 1990-02-09
IE62364B1 (en) 1995-01-25
HU210833B (en) 1995-08-28
EP0350403A1 (fr) 1990-01-10
DK335489A (da) 1990-01-08
TW197440B (https=) 1993-01-01
JPH0267274A (ja) 1990-03-07
US5021420A (en) 1991-06-04
KR0138908B1 (ko) 1998-05-15
EP0350403B1 (fr) 1993-01-13
DK335489D0 (da) 1989-07-06
JP2763791B2 (ja) 1998-06-11
IE892189L (en) 1990-01-07
NO892808D0 (no) 1989-07-06
DE68904364D1 (de) 1993-02-25
FI893297A7 (fi) 1990-01-08
PT91098A (pt) 1990-02-08
NO179007C (no) 1996-07-17
ES2054057T3 (es) 1994-08-01
DE68904364T2 (de) 1993-07-15
IL90858A (en) 1994-08-26
HUT56098A (en) 1991-07-29
US5036075A (en) 1991-07-30
AU620114B2 (en) 1992-02-13
CA1326483C (fr) 1994-01-25
PT91098B (pt) 1994-12-30
FI893297A0 (fi) 1989-07-06
KR900001707A (ko) 1990-02-27
FI93114C (fi) 1995-02-27

Similar Documents

Publication Publication Date Title
HU896776D0 (https=)
AU7003687A (https=)
AU1529688A (https=)
AU1550788A (https=)
AU2171188A (https=)
AU2297688A (https=)
IN169467B (https=)
AU7157587A (https=)
AU7316987A (https=)
AU7442887A (https=)
AU7833687A (https=)
AU7922587A (https=)
AU7925887A (https=)
IN171394B (https=)
BG45088A1 (https=)
BG45126A1 (https=)
BG45154A1 (https=)
BG45157A1 (https=)
BG45179A1 (https=)
BG45189A1 (https=)
BG45228A1 (https=)
BG45242A1 (https=)
BG45264A1 (https=)
BG45276A1 (https=)
BG45282A1 (https=)